Global Transfer Membrane Market - 2022-2029

Market Overview

Transfer Membrane Market size was valued at US$ xx million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of x% during the forecast period (2022-2029).

Transfer membranes are used in blotting techniques as part of the solid phase support upon which proteins or nucleic acids are transferred from gel matrices so that detection and analysis may be performed. After size separation by electrophoresis in agarose gel, polyacrylamide proteins or nucleic acids are stable on a solid matrix membrane, enabling the detection of specific proteins or nucleic acids using antibodies directed against the specific target.

Market Dynamics

The transfer membrane market growth is driven by the rising private and public funding in life science research, increasing research and development activities for targeted diseases and rising advancementnt in biologics

The rising funding for life sciences is expected to drive the market growth

The rising funding from private and public organizations is expected to boost the market over the forecast period. Various mega trends such as demographic, economic, and technological coupled with quick advances in technology have drive life sciences growth in the past years. The life sciences industry has on the rise due to a surge in new products development and technology, as well as an increase of funding from both public and private investors. For instance, the last two years witnessed for tremendous growth with $70 billion of private equity capital and public National Institutes of Health (NIH) funding pouring into life sciences-related companies in North America in 2020 and a record $78 billion in 2021.

In addition, in 2022, Merck group is offered a series of research grants to stimulate innovative research most challenging sectors of future importance. Grants of up to 500,000 € per year for up to 3 years are available in the areas such as drug discovery, innovations within green chemistry, AI for predictive diagnostics & therapeutic target discovery, and others. Increasing funding and research activities to develop new products drive the transfer membrane market globally.

The lack of skilled healthcare professionals will hamper the growth of the market

However, during the pandemic healthcare sector faced a new set of challenges in forcing it to rapidly adapt to the onset of the pandemic and rapidly mobilize to meet the challenge. while the research sector's continued delivery of strong growth means workers have to be skilled in research activities. Lack of skilled healthcare professionals are limits transfer membrane market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global transfer membrane market. In January 2020, the International Health Regulations Emergency Committee of the World Health Organization (WHO) announced that the coronavirus disease (COVID-19) outbreak a public health emergency of internationally. More recently, the COVID-19 pandemic people the life sciences sector to a advanced level of importance with cutting-edge innovations such as to develop vaccines are ongoing in the laboratory to treat infection of coronavirus.

On the other hand, the forceful lockdowns has negatively impacted the production of raw materials for transfer membrane. The supply chain disruptions and transportation restrictions hampered the market globally. As the situation is recovering from COVID-19 the essential requirements are now accessible for research activities. Due to a regulated supply chain and easy availability of raw materials the transfer membrane market is growing worldwide.

Segment Analysis

The western blotting segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The western blotting segment is expected to boost the market over the period of the forecast. The article published in the National Library of Medicine mentioned that western blot is commonly used in research laboratories to separate and identify proteins. In this technique, a mixture of proteins is separated based on molecular weight, through gel electrophoresis. Then, these results are transferred to a membrane producing a band for each protein. This blotting technique is used for indentification of nuclic acids, detection of radioactive probe in the sample. In western blotting technique mainly nitrocellulose and polyvinylidene difluoride (PVDF) are the membranes used for blotting applications. Both membranes are microporous characteristics that bind proteins to their surface via hydrophobic interactions.

Geographical Analysis

North America region holds the largest market share of the global transfer membrane market

North America dominates the market for transfer membrane and is expected to show a similar trend over the forecast period. It is estimated to hold a significant market size over the forecast period (2022-2029) owing to technological advancement, rising funding for life science research, rising innovations in healthcare sectors and presence of market players. The key players such as Pfizer Inc. AstraZeneca, Johnson and Johnson, Merck and others. As per the 2022 Clinical trial.gov data approximately more than 500 active clinical trials are ongoing for different cancer in alone United States.

In addition, the market players are offering the different transfer membrane in the North American Market. For instance, Merck offers four different PVDF membranes including Immobilon E, Immobilon P, Immobilon PSQ and Immobilon FL each developed for different protein blotting applications. These transfer membranes are suitable for western blotting application with broad range of excitation and emission wavelengths.

Competitive Landscape

The transfer membrane market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market are Abcam plc., Thermo Fisher Scientific Inc., PerkinElmer Inc., MACHEREY-NAGEL GmbH & Co. KG, General Electric Company, Carl Roth GmbH + Co. KG, Azure Biosystems, Inc., ATTO Corporation., Bio-Rad Laboratories, Inc., and Advansta Inc. among others. The major players are adopting several growth strategies such as Treatment type launches, acquisitions, and collaborations, which are contributing to the growth of the transfer membrane market globally.

Thermo Fisher Scientific

Overview:

Thermo Fisher Scientific is an analytical laboratory manufacturing company established in 1956, headquartered in United States. It offers the membranes such as nylon, nitrocellulose, PVDF featuring as ease use, high binding capacity and large surface area-to-volume area ratio.

Treatment Type Portfolio:

Nitrocellulose Membranes: It is common matrix used in protein blotting due to their high protein-binding affinity, compatibility with a variety of detection methods, and the ability to immobilize proteins and glycoproteins. it may also be used for the applications such as amino acid analysis ,southern and northern blots, and dot/slot blot.

The global transfer membrane market report would provide access to approximately 75+ market data tables, 75+ figures, and in the range of 250+ (approximate) pages.